Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Epigenetics Diagnostic
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Epigenetics Diagnostic Market By Product
1.2.2.1. Global Epigenetics Diagnostic Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Epigenetics Diagnostic Market Revenue Share By Product in 2017
1.2.2.3. Reagents
1.2.2.4. Kits
1.2.2.4.1. ChIP Sequencing Kit
1.2.2.4.2. Whole Genomic Amplification Kit
1.2.2.4.3. Bisulfite Conversion Kit
1.2.2.4.4. RNA Sequencing Kit
1.2.2.4.5. Others
1.2.2.5. Instruments
1.2.2.6. Enzymes
1.2.2.7. Services
1.2.3. Epigenetics Diagnostic Market By Technology
1.2.3.1. Global Epigenetics Diagnostic Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.3.2. Global Epigenetics Diagnostic Market Revenue Share By Technology in 2017
1.2.3.3. DNA Methylation
1.2.3.3.1. Reagents
1.2.3.3.2. Kits
1.2.3.3.3. Instruments
1.2.3.3.4. Enzymes
1.2.3.3.5. Services
1.2.3.4. Large non-coding RNA
1.2.3.4.1. Reagents
1.2.3.4.2. Kits
1.2.3.4.3. Instruments
1.2.3.4.4. Enzymes
1.2.3.4.5. Services
1.2.3.5. Histone Methylation
1.2.3.5.1. Reagents
1.2.3.5.2. Kits
1.2.3.5.3. Instruments
1.2.3.5.4. Enzymes
1.2.3.5.5. Services
1.2.3.6. Histone Acetylation
1.2.3.6.1. Reagents
1.2.3.6.2. Kits
1.2.3.6.3. Instruments
1.2.3.6.4. Enzymes
1.2.3.6.5. Services
1.2.3.7. Chromatin structures
1.2.3.7.1. Reagents
1.2.3.7.2. Kits
1.2.3.7.3. Instruments
1.2.3.7.4. Enzymes
1.2.3.7.5. Services
1.2.3.8. MicroRNA Modification
1.2.3.8.1. Reagents
1.2.3.8.2. Kits
1.2.3.8.3. Instruments
1.2.3.8.4. Enzymes
1.2.3.8.5. Services
1.2.4. Epigenetics Diagnostic Market By Application
1.2.4.1. Global Epigenetics Diagnostic Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Global Epigenetics Diagnostic Market Revenue Share By Application in 2017
1.2.4.3. Oncology
1.2.4.3.1. Solid Tumors
1.2.4.3.2. Liquid Tumors
1.2.4.4. Non-oncology
1.2.4.4.1. Inflammatory Diseases
1.2.4.4.2. Metabolic Diseases
1.2.4.4.3. Infectious Diseases
1.2.4.4.4. Cardiovascular Diseases
1.2.4.4.5. Others
1.2.5. Epigenetics Diagnostic Market by Geography
1.2.5.1. Global Epigenetics Diagnostic Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Epigenetics Diagnostic Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Epigenetics Diagnostic Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Epigenetics Diagnostic Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Epigenetics Diagnostic Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Epigenetics Diagnostic Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Epigenetics Diagnostic Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Epigenetics Diagnostic Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Epigenetics Diagnostic Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Epigenetics Diagnostic Major Manufacturers in 2017
CHAPTER 4. EPIGENETICS DIAGNOSTIC MARKET BY PRODUCT
4.1. Global Epigenetics Diagnostic Revenue By Product
4.2. Reagents
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Kits
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3.3. ChIP Sequencing Kit
4.3.4. Whole Genomic Amplification Kit
4.3.5. Bisulfite Conversion Kit
4.3.6. RNA Sequencing Kit
4.3.7. Others
4.4. Instruments
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Enzymes
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Services
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. EPIGENETICS DIAGNOSTIC MARKET BY TECHNOLOGY
5.1. Global Epigenetics Diagnostic Revenue By Technology
5.2. DNA Methylation
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.2.3. Reagents
5.2.4. Kits
5.2.5. Instruments
5.2.6. Enzymes
5.2.7. Services
5.3. Large non-coding RNA
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3.3. Reagents
5.3.4. Kits
5.3.5. Instruments
5.3.6. Enzymes
5.3.7. Services
5.4. Histone Methylation
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4.3. Reagents
5.4.4. Kits
5.4.5. Instruments
5.4.6. Enzymes
5.4.7. Services
5.5. Histone Acetylation
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5.3. Reagents
5.5.4. Kits
5.5.5. Instruments
5.5.6. Enzymes
5.5.7. Services
5.6. Chromatin structures
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6.3. Reagents
5.6.4. Kits
5.6.5. Instruments
5.6.6. Enzymes
5.6.7. Services
5.7. MicroRNA Modification
5.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.7.3. Reagents
5.7.4. Kits
5.7.5. Instruments
5.7.6. Enzymes
5.7.7. Services
CHAPTER 6. EPIGENETICS DIAGNOSTIC MARKET BY APPLICATION
6.1. Global Epigenetics Diagnostic Revenue By Application
6.2. Oncology
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.2.3. Solid Tumors
6.2.4. Liquid Tumors
6.3. Non-oncology
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3.3. Inflammatory Diseases
6.3.4. Metabolic Diseases
6.3.5. Infectious Diseases
6.3.6. Cardiovascular Diseases
6.3.7. Others
CHAPTER 7. NORTH AMERICA EPIGENETICS DIAGNOSTIC MARKET BY COUNTRY
7.1. North America Epigenetics Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Epigenetics Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Epigenetics Diagnostic Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 8. EUROPE EPIGENETICS DIAGNOSTIC MARKET BY COUNTRY
8.1. Europe Epigenetics Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Epigenetics Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 9. ASIA-PACIFIC EPIGENETICS DIAGNOSTIC MARKET BY COUNTRY
9.1. Asia-Pacific Epigenetics Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Epigenetics Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 10. LATIN AMERICA EPIGENETICS DIAGNOSTIC MARKET BY COUNTRY
10.1. Latin America Epigenetics Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Epigenetics Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 11. MIDDLE EAST EPIGENETICS DIAGNOSTIC MARKET BY COUNTRY
11.1. Middle East Epigenetics Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Epigenetics Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 12. AFRICA EPIGENETICS DIAGNOSTIC MARKET BY COUNTRY
12.1. Africa Epigenetics Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Epigenetics Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
CHAPTER 13. COMPANY PROFILE
13.1. Roche Diagnostics
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Thermo Fisher Scientific, Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Eisai Co.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Product Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Novartis AG.
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Others
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. Key Developments
13.5.6. Strategies
CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope
